DR-50402

N/A

Report date: 2022/01/05 15:24:33

Base Information

Drug NameDR-50402
Drug Alias NameDR-50402
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionInterleukin-15 receptor subunit alpha stimulantsInterleukin-15 stimulants
TargetsInterleukin-15 receptor subunit alphaInterleukin-15
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesZhejiang Doer Biologics Corp
China Registration ClassN/A

Develop Information

Active CompaniesZhejiang Doer Biologics Corp
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A